GM21655
LCL from B-Lymphocyte
Description:
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2
CENTROSOMAL PROTEIN, 57-KD; CEP57
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Chromosome Abnormalities |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Ethnicity
|
Hispanic/Latino
|
|
Ethnicity
|
MEXICAN
|
|
Family Member
|
2
|
|
Relation to Proband
|
sister
|
|
Confirmation
|
Karyotypic analysis before cell line submission to CCR
|
|
ISCN
|
45-50,XX,-X[1],1qh+,+1qh+[1],+2[1],+3[2],+5[1],+6[1],+7[3],+9[4],+12[2],+13[1],+14[2],+15[1],+16[2],+17[1],+18[1],+22[1][cp50]
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin confirmed by LINE assay |
| |
| Gene |
CEP57 |
| Chromosomal Location |
11q21 |
| Allelic Variant 1 |
607951.0001; MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2 |
| Identified Mutation |
c.520_521del (p.Glu174fs) |
| |
| Gene |
CEP57 |
| Chromosomal Location |
11q21 |
| Allelic Variant 2 |
607951.0002; MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2 |
| Identified Mutation |
c.915_925dup (p.Leu309fs) |
| Remarks |
Intrauterine growth retardation observed at 25 weeks of gestation; similar facial dysmorphism as her affected brother (GM21654); triangular face; flat nasal bridge; palpebral fissures slant down; micrognathia; molecular analysis showed no BUB1B mutation |
| Watanabe K, Takao D, Ito KK, Takahashi M, Kitagawa D, The Cep57-pericentrin module organizes PCM expansion and centriole engagement Nature communications10:931 2017 |
| PubMed ID: 30804344 |
| Split Ratio |
1:3 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|
|